Loading...

ATNM ACTINIUM PHARMACEUTICALS INC Management Changes 8-K Filing

CTNM

TNM

ACTINIUM PHARMACEUTICALS INC

(ATNM)

2024 8-K

Voting Frequency Update

Management Changes

Annual Meeting Results

Director Elections

Director Appointment

Regulatory Update

Election of Class I Directors

Regulation FD Disclosure

Phase 3 SIERRA trial results

External Links:

Dr. June Almenoff was appointed as a director of Actinium Pharmaceuticals, Inc. on November 1, 2024, and granted stock options for 50,000 shares at an exercise price of $1.71 per share.

AI Assistant

ACTINIUM PHARMACEUTICALS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.